Endometrial cancer is platinum-resistant if it continues to grow or comes back within 6 months of treatment with carboplatin or cisplatin. The cancer may spread to areas outside your endometrium ...

Approximately 25% of women develop recurrence or distant metastasis. Laparoscopic surgery for stage I endometrial cancer produces better short-term outcomes and fewer severe postoperative ...

But when left untreated, endometrial cancer may start to spread through the wall of the uterus and into the pelvis, causing ...

A coroner found there were "missed opportunities" to treat a 38-year-old woman with cancer. Carla Smith, 38, who died on 7 ...

A thorough medical history and physical exam A pelvic exam and Pap test Imaging tests such as a transvaginal ultrasound, X-ray, or computed tomography (CT or CAT) scan to not only diagnose uterine ...

Although anyone with endometrial cancer can have mental health challenges, the risk appears to be higher in people with advanced cancer that has spread beyond the uterus. These might be signs of a ...

In most cases, we only recommend other therapies — such as chemotherapy, hormone therapy, or radiation therapy — if the cancer has spread into the deep uterine muscle layer or beyond. We also offer ...

The results of a multisite clinical trial overseen by University of Colorado Cancer Center member Bradley Corr, MD, could offer new hope to patients with metastatic and recurrent uterine cancer ...

The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...